2018
Network Optimization And The Continuity Of Physicians In Medicaid Managed Care
Ndumele CD, Staiger B, Ross JS, Schlesinger MJ. Network Optimization And The Continuity Of Physicians In Medicaid Managed Care. Health Affairs 2018, 37: 929-935. PMID: 29863934, DOI: 10.1377/hlthaff.2017.1410.Peer-Reviewed Original ResearchMeSH KeywordsChronic DiseaseContinuity of Patient CareCost ControlDatabases, FactualDelivery of Health CareFemaleHealth ExpendituresHealth Maintenance OrganizationsHealth Services AccessibilityHumansMaleManaged Care ProgramsMedicaidPhysiciansPractice Patterns, Physicians'Retrospective StudiesUnited States
2017
Association between FDA black box warnings and Medicare formulary coverage changes.
Dhruva SS, Karaca-Mandic P, Shah ND, Shaw DL, Ross JS. Association between FDA black box warnings and Medicare formulary coverage changes. The American Journal Of Managed Care 2017, 23: e310-e315. PMID: 29087169.Peer-Reviewed Original ResearchConceptsFDA black box warningBlack box warningNew black box warningsBox warningCardiovascular riskDrug alternativesNew safety informationMajority of drugsFormulary changeRetrospective analysisFormulary coverageFormularyDrugsCapsule formulationSubstantial proportionMedicationsDeathRiskSafety informationFDAYears
2016
Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults
Kronish IM, Ross JS, Zhao H, Muntner P. Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults. Circulation Cardiovascular Quality And Outcomes 2016, 9: 364-371. PMID: 27220368, PMCID: PMC4956547, DOI: 10.1161/circoutcomes.115.002418.Peer-Reviewed Original ResearchMeSH KeywordsAdministrative Claims, HealthcareAgedAged, 80 and overDatabases, FactualDyslipidemiasFemaleHealth Knowledge, Attitudes, PracticeHospitalizationHumansHydroxymethylglutaryl-CoA Reductase InhibitorsMaleMedicareMedication AdherenceMyocardial InfarctionRisk AssessmentRisk FactorsTherapeuticsTime FactorsUnited StatesConceptsAcute myocardial infarctionImpact of hospitalizationAMI hospitalizationMyocardial infarctionProportion of patientsPatients adherentStatin adherentNonadherent patientsAdherent patientsMedicare patientsHospitalizationAdministrative claimsStatinsMedicare beneficiariesPatientsPneumoniaSubsequent adherenceOlder adultsInfarctionRandom sampleAdherenceAdherentYearsProportionCohort
2015
Revisiting Essure — Toward Safe and Effective Sterilization
Dhruva SS, Ross JS, Gariepy AM. Revisiting Essure — Toward Safe and Effective Sterilization. New England Journal Of Medicine 2015, 373: e17. PMID: 26397951, DOI: 10.1056/nejmp1510514.Commentaries, Editorials and Letters
2011
Assessing the Impact of Screening Colonoscopy on Mortality in the Medicare Population
Gross CP, Soulos PR, Ross JS, Cramer LD, Guerrero C, Tinetti ME, Braithwaite RS. Assessing the Impact of Screening Colonoscopy on Mortality in the Medicare Population. Journal Of General Internal Medicine 2011, 26: 1441-1449. PMID: 21842323, PMCID: PMC3235614, DOI: 10.1007/s11606-011-1816-4.Peer-Reviewed Original ResearchConceptsColorectal cancerStrata of sexYears of ageShort life expectancyDesignRetrospective studyResultsIncreasing ageWomen 75Greater comorbidityOlder patientsScreening colonoscopyComorbiditiesRoutine screeningMedicare populationMortality ratePatientsAge groupsEffectiveness of SCMortalityLife expectancyWomenAgeMenColonoscopySexYears
2009
Economic Evaluation of a Comprehensive Teenage Pregnancy Prevention Program Pilot Program
Rosenthal MS, Ross JS, Bilodeau R, Richter RS, Palley JE, Bradley EH. Economic Evaluation of a Comprehensive Teenage Pregnancy Prevention Program Pilot Program. American Journal Of Preventive Medicine 2009, 37: s280-s287. PMID: 19896030, PMCID: PMC3020976, DOI: 10.1016/j.amepre.2009.08.014.Peer-Reviewed Original ResearchConceptsTeenage pregnancy prevention programsAge 30 yearsPregnancy prevention programsPrevention programsCommunity-based participatory research approachProgram operating costsTotal societal costsUnintended pregnancySocietal economic benefitsHigh-risk neighborhoodsCost effectivenessParticipatory research approachYoung adultsSocietal costsEconomic benefitsAdolescentsTeenage girlsEconomic evaluationComprehensive programPilot programYearsTotal social costSexual educationNeighborhood-based programsProgram participationPooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data: Lessons for Postmarket Pharmaceutical Safety Surveillance
Ross JS, Madigan D, Hill KP, Egilman DS, Wang Y, Krumholz HM. Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data: Lessons for Postmarket Pharmaceutical Safety Surveillance. JAMA Internal Medicine 2009, 169: 1976-1985. PMID: 19933959, PMCID: PMC2830805, DOI: 10.1001/archinternmed.2009.394.Peer-Reviewed Original ResearchMeSH KeywordsAdverse Drug Reaction Reporting SystemsCardiovascular SystemCyclooxygenase 2 InhibitorsDrug IndustryHumansIncidenceLactonesMyocardial InfarctionRandomized Controlled Trials as TopicRisk AssessmentSafety-Based Drug WithdrawalsSulfonesTime FactorsUnited StatesUnited States Food and Drug AdministrationConceptsPlacebo-controlled trialVoluntary market withdrawalAdverse eventsCardiovascular riskThromboembolic adverse eventsMain outcome measurementsClinical trial dataRofecoxib groupOutcome measurementsTrial dataPlaceboTrial durationSafety surveillanceTrialsMarket withdrawalDeathRiskP-valueSurveillance effortsSubjectsWithdrawalRofecoxibYearsIncidenceDoseExposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures
Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH, Shah ND, Nasir K, Einstein AJ, Nallamothu BK. Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures. New England Journal Of Medicine 2009, 361: 849-857. PMID: 19710483, PMCID: PMC3707303, DOI: 10.1056/nejmoa0901249.Peer-Reviewed Original ResearchConceptsCumulative effective dosesCumulative effective doseEffective dosesEffective doseMean cumulative effective doseImaging proceduresLow-dose ionizing radiationPopulation-based ratesMedian effective doseOutpatient settingGeneral populationHigh dosesUtilization dataDosesEnrolleesStudy periodRadiation exposureNuclear imagingDoseAnnual effective dosesMedical imaging proceduresUnited StatesExposureHealth care marketYears